Congress moves to stock workplaces with overdose-reversal kits
H.R. 7479 — WORK to Save Lives Act · Filed by Bonnie Watson Coleman (D-NJ) · 16 cosponsors · Introduced Feb 10, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the Department of Labor to issue non-binding guidance to private employers on acquiring opioid overdose reversal medication (like naloxone) and offering voluntary annual training to employees on how to use it. It separately mandates that federal agencies themselves must acquire and maintain such medication and offer the same voluntary training to their employees.
Why we flagged it
The bill's operative mechanism is straightforward: it directs the Department of Labor to create guidance and regulations aimed at making opioid overdose reversal medication available in workplaces. This is a public-health intervention, not a regulatory carve-out or industry subsidy.
What the text implies
- The bill excludes the U.S. Postal Service from the private-employer guidance requirement, creating a gap in coverage for a large federal employer that handles mail and interacts with the public.
- Voluntary training language may result in low uptake if employers face no enforcement mechanism; effectiveness depends on employer buy-in and follow-through.
- The bill does not specify funding for medication acquisition or training delivery, leaving cost burden on employers and federal agencies; implementation may vary widely by agency.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Workers gain access to opioid overdose reversal medication and training at their workplace, potentially saving lives during overdose emergencies. The bill imposes no costs on workers and only encourages (for private employers) or requires (for federal agencies) employers to stock a low-cost, life-saving medication and provide training.
Who stands to gain
- pharmaceutical manufacturers of naloxone/opioid reversal medications
- workplace safety training providers
Named in the bill
Department of Labor, Occupational Safety and Health Administration (OSHA), Federal agencies, Veterans Health Administration, U.S. Postal Service, Occupational Safety and Health Act of 1970
Where it stands
16 cosponsors: 15 Democrats, 1 Republicans.
- Feb 10, 2026 — Introduced · Congress.gov: “Introduced in House”
- Feb 10, 2026 — Referred to House Committee on Education and Workforce · Congress.gov: “Referred to the House Committee on Education and Workforce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
3 lobbying clients named this bill on 3 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $210,555 in lobbying spend. A filing names 12 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 61% of bills with at least one filing.
- National Council for Behavioral Health — $150,555 on 1 filing
- Tobacco-free Kids Action Fund Fka Global Health Advocacy Incubator (ghai) — $40,000 on 1 filing
- Kelley Drye & Warren Llp Obo Tobacco-free Kids Action Fund — $20,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,552 characters) on Aug 17, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
- H.R. 7479 on Congress.gov
- Actions and status history
- Cosponsors (16)
- Bill text the analysis read
- National Council for Behavioral Health — LDA filing, 2026 Q2
- Tobacco-free Kids Action Fund Fka Global Health Advocacy Incubator (ghai) — LDA filing, 2026 Q2
- Kelley Drye & Warren Llp Obo Tobacco-free Kids Action Fund — LDA filing, 2026 Q2
- Bonnie Watson Coleman — FEC candidate receipts, 2026 cycle
“Congress moves to stock workplaces with overdose-reversal kits” QuorumCivic. https://share.quorumcivic.app/bill/119/hr7479 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.